Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV001563605 | SCV001786580 | uncertain significance | Harel-Yoon syndrome | 2021-01-14 | criteria provided, single submitter | clinical testing | The ATAD3A c.412C>T (p.Arg138Trp) variant, is a missense variant. A literature search was performed for the gene, cDNA change, and amino acid change. No publications were found based on this search. This variant is reported at a frequency of 0.000087 in the European (non-Finnish) population of the Genome Aggregation Database. Based on the limited evidence, the p.Arg138Trp variant is classified as a variant of uncertain significance for Harel-Yoon syndrome. |
Fulgent Genetics, |
RCV002501909 | SCV002780481 | uncertain significance | Harel-Yoon syndrome; Pontocerebellar hypoplasia, hypotonia, and respiratory insufficiency syndrome, neonatal lethal | 2022-01-06 | criteria provided, single submitter | clinical testing | |
Gene |
RCV002508318 | SCV002818019 | uncertain significance | not provided | 2023-10-11 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Ambry Genetics | RCV003161103 | SCV003864065 | uncertain significance | Inborn genetic diseases | 2023-02-16 | criteria provided, single submitter | clinical testing | The c.556C>T (p.R186W) alteration is located in exon 4 (coding exon 4) of the ATAD3A gene. This alteration results from a C to T substitution at nucleotide position 556, causing the arginine (R) at amino acid position 186 to be replaced by a tryptophan (W). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Duke University Health System Sequencing Clinic, |
RCV003223423 | SCV003919081 | uncertain significance | Pontocerebellar hypoplasia, hypotonia, and respiratory insufficiency syndrome, neonatal lethal | 2023-04-20 | criteria provided, single submitter | research |